Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2008

View Archived Issues

MDV-3100 well tolerated, reduces PSA in castration-resistant prostate cancer patients

In vitro and in vivo activity against hepatocellular cancer seen with CUDC-101

PDL BioPharma reports development of anti-TweakR antibody with antitumor activity

Serenex describes discovery of SNX-5422, an Hsp90 inhibitor in phase I development

F-14512 activity depends on polyamine transport system status of tumors

Positive preclinical data of Palomid-529 in models of ocular disorders

Evotec completes acquisition of Renovis

Corcept reports promising results from human microdosing study of CORT-108297

Epix initiates phase IIb clinical trial of PRX-03140 in combination with Aricept

NanoViricides reports initial results from mouse studies of HivCide-I for HIV/AIDS

Antennapedia Trojan peptide-p21 fusion protein inhibits tumor cell growth

Bayer Schering Pharma to market new low-dose oral contraceptive in Europe

TG-100801's clinical evaluation discontinued due to phase IIa results

Catalyst selects second-generation factor VIIa variant as candidate for hemophilia

DiaMedica enrolls final patient in phase DM-83 clinical trial

FDA accepts for review Cinryze complete response submission

QRxPharma releases successful phase III study results for Q-8003-IR

Cadence completes full enrollment in phase III CLIRS clincial trial of Omigard

FDA Advisory Committee recommends against approval of Fentora expanded label

Genentech initiates phase II clinical trial of GDC-0449 in metastatic colorectal cancer

Novel agents for treating autoimmune diseases disclosed in recent Pharmacopeia patents

Targacept designates neuronal nicotinic receptor drug in smoking cessation program

Recent patents claim novel therapeutic agents for psychosis, depression and anxiety

LLS and MannKind enter agreement to develop targeted tyrosine kinase inhibitor

Glenmark launches topical antifungal cream Onabet in India

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...